Form 4: Acelyrin Chief Medical Officer Sells Shares to Cover Tax Obligations

Shephard Mpofu, Chief Medical Officer of Acelyrin, Inc., sold 3,211 shares of common stock on March 17, 2025, to cover tax obligations related to vested restricted stock units.

Summary

• On March 17, 2025, Shephard Mpofu, the Chief Medical Officer of Acelyrin, Inc. (SLRN), sold 3,211 shares of the company's common stock.
• The sale was executed to cover tax obligations arising from the vesting and settlement of restricted stock units.
• The shares were sold at a weighted average price of $2.744, with individual transactions occurring between $2.71 and $2.76.
• Following the transaction, Mpofu directly owns 121,789 shares of Acelyrin, Inc.

Sentiment

Score: 6

Explanation: The Form 4 filing itself is neutral. The sale is related to tax obligations, which is a common practice. Therefore, the sentiment is moderately neutral.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares could have a minor, temporary impact on the stock price, but is unlikely to be significant given the relatively small number of shares involved.

Key Dates

Keywords

Acelyrin, SLRN, Shephard Mpofu, Chief Medical Officer, Form 4, Stock Sale, Tax Obligations, Restricted Stock Units, Beneficial Ownership